Parkman Healthcare Partners LLC 13F Holdings
CIK 0001777015 · STAMFORD, CT
As of Sep 30, 2025, Parkman Healthcare Partners LLC reported 91 positions worth $958.7M in its SEC Form 13F filing.
Top 25 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| INVESCO QQQ TRUST SERIES 1 | QQQ | — | 80,000 | $48.0M | 5.01% |
| BOSTON SCIENTIFIC CORP | BSX | Healthcare | 434,377 | $42.4M | 4.42% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | Healthcare | 87,690 | $40.0M | 4.17% |
| INSULET CORP | PODD | Healthcare | 116,238 | $35.9M | 3.74% |
| CVS HEALTH CORP | CVS | Healthcare | 379,486 | $28.6M | 2.98% |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | KNSA | Healthcare | 671,592 | $26.1M | 2.72% |
| VIRIDIAN THERAPEUTICS INC | VRDN | Healthcare | 1,154,487 | $24.9M | 2.60% |
| ZIMMER BIOMET HOLDINGS INC | ZBH | Healthcare | 251,420 | $24.8M | 2.58% |
| STRYKER CORP | SYK | Healthcare | 64,108 | $23.7M | 2.47% |
| QIAGEN NV | QGEN | Healthcare | 500,159 | $22.3M | 2.33% |
| MCKESSON CORP | MCK | Healthcare | 28,542 | $22.0M | 2.30% |
| DANAHER CORP | DHR | Healthcare | 110,541 | $21.9M | 2.29% |
| KALVISTA PHARMACEUTICALS INC | KALV | Healthcare | 1,735,003 | $21.1M | 2.20% |
| UNIQURE NV | QURE | Healthcare | 345,356 | $20.2M | 2.10% |
| NEUROCRINE BIOSCIENCES INC | NBIX | Healthcare | 141,822 |